Related Experiment Video
Updated: Jun 13, 2026

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
Published on: August 25, 2019
Changes in fetal prevalence and outcome for trisomies 13 and 18: a population-based study over 23 years
Claire Irving1, Sam Richmond, Christoper Wren
1Department of Paediatric Cardiology, Freeman Hospital, Newcastle Upon Tyne NE7 7DN, UK.
Insights
Prenatal diagnosis and increased maternal age have significantly reduced live births of trisomy 13 and trisomy 18. However, infant survival rates for these conditions remain poor, with most infants dying shortly after birth.
Area of Science:
- Genetics and Genomics
- Reproductive Health
- Pediatric Medicine
Background:
- Trisomy 13 (Patau syndrome) and trisomy 18 (Edwards syndrome) are severe chromosomal abnormalities.
- Trends in prenatal diagnosis and maternal age influence live birth prevalence and outcomes.
Purpose of the Study:
- To investigate trends in the diagnosis, prevalence, and survival rates of trisomy 13 and trisomy 18.
- To assess the impact of changes in prenatal screening and maternal age on these conditions.
Main Methods:
- Population-based study utilizing a congenital abnormality register in a UK health region (1985-2007).
- Review of individual records to obtain live birth and maternal age data.
Main Results:
- Pregnancies with trisomy 13 and 18 increased, with higher prenatal diagnosis rates and associated termination rates.
- Live born prevalence of trisomy 13 decreased from 0.05 to 0.03 per 1000 live births; trisomy 18 decreased from 0.16 to 0.10 per 1000 live births.
- One-year survival remained poor (3% for trisomy 13, 6% for trisomy 18), with maternal age over 35 increasing from 6% to 15%.
Conclusions:
- Changes in prenatal screening and increasing maternal age have significantly impacted live born prevalence of trisomies 13 and 18.
- Infant survival rates for these conditions have not improved, with most deaths occurring in the neonatal period.
Objective:
Changes in prenatal diagnosis and maternal age are likely to have an impact on live born prevalence of trisomies 13 and 18. We investigated trends in diagnosis, prevalence, and survival in these conditions.
Methods:
A population-based study of one UK health region in 1985-2007 using a well-established congenital abnormality register. Individual records were reviewed and live birth and maternal age data obtained.
Results:
Pregnancies with trisomies 13 and 18 increased from 0.08 to 0.23 per 1000 registered births and 0.20 to 0.65 per 1000 registered births, respectively. Prenatal diagnosis increased and was associated with high termination rates. Live born prevalence with trisomy 13 decreased from 0.05 to 0.03 per 1000 live births and with trisomy 18 from 0.16 to 0.10 per 1000 live births. Postnatal survival remains poor: one baby (3%) with trisomy 13 and four (6%) with trisomy 18 survived the first year. The percentage of mothers over 35 years increased from 6 to 15%.
Conclusions:
Changes in prenatal screening and maternal age have had dramatic effects on the live born prevalence of trisomies 13 and 18. Infant survival remains largely unchanged with the majority dying in the neonatal period.
Related Concept Videos
Meiosis vs. Mitosis
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Nondisjunction
Nondisjunction
Regression Toward the Mean
Meiosis I
Teratogenicity
